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Symposia

Cannabis and Psychosis: From
Neuroscience to Clinical Intervention
(NISAD Symposium)
A Baker
Centre for Mental Health Studies, The University of Newcastle, New South Wales,
Australia

Overview
Cannabis use has been associated with the onset,
course and relapse of psychosis. Population studies
and data from samples of young people at high risk
for psychosis have indicated that cannabis use may
be related to the onset of psychosis. Cannabis use has
also been found to have a deleterious impact on psychotic symptom severity and has emerged as the strong
predictor of psychotic relapse. To date, there has been
little collaboration between neuroscience and clinical
research groups examining the link between cannabis
use and psychosis, despite the potential for these fields
to inform the other. This symposium seeks to begin to
redress this gap.
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Methods: Heterozygous Nrg1 transmembrane-domain
knockout mice (Nrg1 HET) were treated with acute
THC (0, 5 or 10 mg/kg i.p.) 30 min before being
tested in the open field (OF), hole board, light-dark
(LD), elevated plus maze (EPM), social interaction
(SI) and prepulse inhibition (PPI) tests.
Results: Nrg1 HET mice showed differences in baseline behaviour in regard to locomotor activity, exploration and anxiety. More importantly, they were more
sensitive to the locomotor suppressant actions of THC
compared with wild-type-like (WT) mice. In addition,
Nrg1 HET mice expressed a greater THC-induced enhancement in per cent PPI than WT mice. The effects
of THC on anxiety-related behaviour were task dependent, with Nrg1 HET mice being more susceptible than
WT mice to the anxiogenic effects of THC in LD, but
not in the EPM, SI and OF tests.
Conclusions: Nrg1 HET mice were more sensitive
to the acute effects of THC in an array of different
behaviours including those that model symptoms of
schizophrenia. It appears that variation in the schizophrenia-related neuregulin 1 gene alters the sensitivity
to the behavioural effects of cannabinoids.
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Heterozygous neuregulin 1 mice are
more sensitive to the behavioural
effects of D9-tetrahydrocannabinol
JC Arnold1,2, AA Boucher1,2,3, L Duffy2,4,
PR Schoﬁeld2,4,5,6, J Micheau3, TF Karl2,4
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Department of Pharmacology, University of Sydney, Sydney, New South Wales,
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Rationale: Environmental stressors such as cannabis
use may precipitate schizophrenia especially if the
individual has a genetic vulnerability to the disease.
Human and animal research indicates that neuregulin
1 (Nrg1) is a susceptibility gene for schizophrenia.
Aim: The aim of this study was to investigate whether
dysfunction in the Nrg1 gene modulates the behavioural effects of 9-tetrahydrocannabinol (THC), the
major psychotropic component of cannabis.
© Blackwell Munksgaard, Acta Neuropsychiatrica, 18, 313–340

Cannabis and cognitive function:
relevant to psychosis
N Solowij
Illawarra Institute for Mental Health, School of Psychology, University of
Wollongong, Wollongong, New South Wales, Australia

Cognitive impairments are among the most debilitating symptoms of mental illness and most highly predictive of functional outcomes. Cannabis intoxication
impairs cognitive processes and there is increasing evidence for longer lasting impairment with long-term or
heavy cannabis use. Cognitive dysfunction associated
with chronic cannabis use is similar in many respects
to the cognitive endophenotypes that have recently
been proposed as vulnerability markers of schizophrenia. The prevalence of cannabis use among people
with psychotic disorders, the potential for cannabis
to trigger psychotic symptoms and episodes, and the
neurobiological interactions between the endogenous
cannabinoid system and the pathology associated
with psychosis indicate a need to further investigate
the nature and mechanisms of cognitive impairments
associated with cannabis use. The endogenous cannabinoid system plays a significant role in attention,
learning and memory in particular, and in mediating
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inhibitory and excitatory regulatory mechanisms in
the brain. There is evidence that the endocannabinoid
system is altered in schizophrenia and accumulating
evidence of disturbances in the system associated with
exposure to cannabis or cannabinoids. This presentation will summarize what is known about the longterm cognitive effects of cannabis, describing some
of the most recent research and its relevance to
psychotic disorders.
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fMRI in schizophrenia and cannabis
users
M Cohen1,2,4, V Carr1,2,4, PB Ward3,4, T Ehlkes4,
P Johnston2,4, R Thienel4, U Schall1,2,4
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Hunter New England Mental Health; 2Centre for Mental Health Studies, The
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Background: The cerebral activation changes associated with the overlapping cognitive features of cannabis use and schizophrenia have not been systematically
studied. The Tower of London Task (TOL) was used to
assess functional brain activation in these two groups
and in comorbid first-episode schizophrenia and cannabis users.
Methods: Event-related functional magnetic resonance imaging measured cerebral activation during the
TOL task in 12 patients with first-episode schizophrenia, 17 recently abstinent long-term cannabis users, 7
recently abstinent cannabis using patients with schizophrenia and 17 healthy subjects. A two-stage randomeffects analysis was used to model the BOLD response
to assess cortical activation as a function of increasing
task difficulty and to assess for the main effect of each
diagnosis.
Results: We found prefrontal activation deficits in patients with schizophrenia that overlapped with cannabis users. A statistical trend in the comorbid subjects
for reduced BOLD activation in the left superior parietal lobule and prefrontal cortices was observed. The
diagnosis of schizophrenia largely accounted for the
prefrontal deficit, while a history of heavy cannabis
use associated with increased BOLD activation in the
visual cortex.
Conclusions: There were common deficits in activation
of the dorsolateral prefrontal cortex to the most difficult tasks. Ancillary brain regions were recruited, possibly to subserve the demands of complex TOL tasks.
The combination of cannabis use and schizophrenia
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may exert a synergistic effect on altering frontal lobe
recruitment during high-demand cognitive tasks.
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Visual scanpath comparisons
between those people with and
without comorbid cannabis abuse:
the implications for eye movement
research in schizophrenia
C Loughland1,2, K McCabe1,2, S Quinn2, M Hunter1,2,
T Lewin1,3
1
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Wales, Australia; 2The University of Newcastle, Callaghan, New South Wales,
Australia; and 3Hunter New England Health, Newcastle, Australia

Background: Cannabis use is associated with substantial social cognition impairment, as are illnesses such
as schizophrenia. Schizophrenia is also strongly associated with comorbid cannabis use. Studies examining
face processing disturbances show that people with
schizophrenia display impaired visual scanpath (VS)
strategies when viewing face stimuli. No studies to
date have examined the impact of cannabis use on VS
performance, and whether VS disturbances in schizophrenia are further impaired by comorbid cannabis
use. This study examines whether VS disturbances to
face stimuli are observed in cannabis users.
Methods: The sample consisted of 20 subjects with
regular cannabis use and 20 healthy controls. Subjects
were screened for psychosis (SCID-N/P). IQ was assessed using the NART and neuropsychological functioning using the RBANS. Personality was assessed
using the SPQ and the IPDE. VSs were recorded using
a ViewPoint (6.0) eye tracker. Recognition accuracy
was recorded concurrently.
Results: Preliminary analysis indicates that the two
groups did not differ from each other on age, gender,
secondary school completion, IQ or neuropsychological functioning. However, cannabis users had significantly higher scores than controls on the SPQ items of
odd beliefs/magical thinking and odd speech, but did
not differ from each other on VS or facial expression
recognition accuracy.
Conclusions: These findings suggest that the social
cognition disturbances observed in cannabis users
may be associated with social cue and personality disturbances rather than disturbances in face perception
and processing. The implications for VS research in
schizophrenia will be discussed.

